VANCOUVER, British Columbia - June 1, 2012 - Positive results from clinical trials exploring algal DHA supplementation during pregnancy and infancy were presented this week at the 10th Congress of the International Society for the Study of Fatty Acids and Lipids (ISSFAL) - an international scientific society focused on research of dietary fats, oils and lipids.
Benefits of Algal DHA During Pregnancy
Research presented by Susan E. Carlson, PhD, at the Department of Dietetics and Nutrition at the University of Kansas Medical Center indicated that prenatal algal DHA supplementation (600 mg of DHA from 14 weeks gestation until delivery) increased DHA blood levels in both the mother and newborn, as well as infant birth weight, length and head circumference.
Additionally, results presented from a study led by Kelly Mulder, PhD, and Sheila Innis, PhD, both from the Department of Pediatrics, Child and Family Research Institute at the University of British Columbia, suggest that DHA deficiency during pregnancy may limit infants' development potential.
Benefits of Algal DHA During Infancy
John Colombo, PhD, presented data from the DHA Intake and Measurement of Neural Development (DIAMOND) clinical trial, which investigated whether DHA and ARA supplemented infant formula affects children's cognitive performance from 18 months to six years of age. Results from the study indicated that DHA and ARA supplementation provided developmental benefits evident to six years of age.
The Importance of DHA Throughout Life
DHA is a polyunsaturated omega-3 fatty acid found throughout the body. It is a major structural fat in the brain and retina, accounting for up to 97 percent of the omega-3 fats in the brain and up to 93 percent of the omega-3 fats in the retina. Numerous studies confirm that everyone, from infants to adults, benefits from an adequate supply of DHA. Throughout every stage of life, DHA is proven to be important for brain and eye health.
life'sDHA™, used in the studies, is a vegetarian and sustainable source of DHA. It can be found in more than 550 products around the world, including supplements and fortified foods and beverages. Additional information about life'sDHA is available at http://www.lifesdha.com.
To speak with the researchers, please contact Cassie France-Kelly at cassie.francekelly@dsm.com or +1 443-710-9373.
To learn more about the studies presented at the 10th Congress of the International Society for the Study of Fatty Acids and Lipids, visit http://www.issfal.org.
DSM - Bright Science. Brighter Living.™
Royal DSM N.V. is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders.
DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM's 22,000 employees deliver annual net sales of about € 9 billion. The company is listed on NYSE Euronext. More information can be found at www.dsm.com.
For more information:
DSM Nutritional Products
Cassie France-Kelly
tel. + 1 443-710-9373
e-mail cassie.francekelly@dsm.com
Forward-looking statements
This press release may contain forward-looking statements with respect to DSM's future (financial) performance and position. Such statements are based on current expectations, estimates and projections of DSM and information currently available to the company. DSM cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. DSM has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is leading.